ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 10

Fibronectin Fragment Induces Procatabolic Effects Through TLR-2 Signaling Pathway in Human Articular Chondrocytes

Su Jin Park1, Eun-Jeong Cheon2 and Hyun Ah Kim3, 1Department of Internal Medicine, Hallym University Sacred Heart Hospital, Kyunggi, South Korea, 2Department of internal medicine, Hallym University Sacred Heart Hospital, Kyunggi, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Hallym university, Kyunggi, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cartilage, chondrocytes, extracellular matrix proteins and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fibronectin fragments (FN-fs) are increased in the synovial fluid of osteoarthritis patients and have a potent chondrolytic effect. However, little is known about the cellular receptors and signaling mechanisms that are mediated by FN-fs. Here we investigated whether the 29-kDa amino-terminal fibronectin fragment (29-kDa FN-f) regulates cartilage metabolism through Toll-like receptor-2 (TLR-2) signaling pathway in human articular chondrocytes.

Methods: Human articular chondrocytes were enzymatically isolated from articular cartilage and cultured in monolayer. In order to investigate whether 29-kDa FN-f induces MMPs production through TLR-2, human chondrocytes were transfected with TLR-2 expression plasmid or small interfering RNAs (siRNAs) targeting TLR-2 and Myeloid differentiation factor 88 (MyD88). In 29-kDa FN-f-stimulated chondrocytes, the relative levels of mRNA for matrix metalloproteinase 1 (MMP-1), MMP-3, and MMP-13 were analyzed by real-time quantitative reverse transcription-polymerase chain reaction. Protein expression levels of MMP-1 and MMP-3 and the regulatory effect of TLR-2 on 29-kDa FN-f-mediated signaling pathways were assessed by immunoblotting. MMP-13 production was measured by ELISA assay. Association of 29-kDa FN-f with human chondrocytes through TLR-2 was evaluated by fluorescence microscopic analysis.

Results: The expression levels of TLR-2, 3, 4, and 5 in TLR family were remarkably elevated in OA cartilage compared to normal cartilage. But, TLR-1 expression of normal and OA cartilages was not significantly different. When human chondrocytes were stimulated with various fibronectin fragments, TLR-2 expression was highly increased by 29-kDa FN-f stimulation. Knockdown of TLR-2 expression using siTLR-2 significantly suppressed 29-kDa FN-f-induced MMPs production in human normal and OA chondrocytes. Conversely, overexpression of TLR-2 enhanced 29-kDa FN-f-stimulated MMPs production. Moreover, we found that knockdown of MyD88, a downstream adaptor in TLR-2 signaling pathways, led to marked reduction of MMPs production induced by 29-kDa FN-f. In addition, 29-kDa FN-f-mediated phosphorylation of IkBa and p38 was apparently inhibited by transfection of siTLR-2. However siTLR-2 treatment did not affect 29-kDa FN-f-induced activation of JNK and ERK. Notably, fluorescence microscopic analysis showed direct interaction between TLR-2 and 29-kDa FN-f in human chondrocytes.

Conclusion: MyD88-dependent TLR-2 signaling pathway plays an important role in 29-kDa FN-f-stimulated procatabolic responses of human chondrocytes. Modulation of TLR-2-mediated signaling may be as a potential therapeutic strategy for the prevention of cartilage degradation in OA.


Disclosure:

S. J. Park,
None;

E. J. Cheon,
None;

H. A. Kim,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibronectin-fragment-induces-procatabolic-effects-through-tlr-2-signaling-pathway-in-human-articular-chondrocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology